Here's the live share price of Astal Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Astal Laboratories has gained 60.05% CAGR. Over the past year, the corresponding return has been -1.83%.
Astal Laboratories’s current P/E of 10.17x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Breakout Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Astal Laboratories | -3.45 | 4.52 | 9.22 | 17.13 | -1.83 | 50.07 | 60.05 |
| Sun Pharmaceutical Industries | 0.33 | 2.35 | 3.15 | -7.76 | -6.42 | 17.65 | 27.40 |
| Divi's Laboratories | 6.12 | 17.18 | 5.13 | 11.31 | 15.80 | 22.16 | 16.40 |
| Cipla | -4.08 | -0.53 | -0.64 | -2.42 | -4.97 | 9.52 | 14.02 |
| Torrent Pharmaceuticals | -0.10 | 1.39 | -1.07 | 8.86 | 11.75 | 28.91 | 22.42 |
| Dr. Reddy's Laboratories | -6.95 | -3.82 | -2.01 | 2.41 | -5.30 | 9.89 | 4.00 |
| Zydus Lifesciences | -2.85 | -2.16 | 1.37 | 9.05 | -3.13 | 30.30 | 17.26 |
| Mankind Pharma | -1.47 | -3.37 | -9.86 | -1.93 | -13.37 | 18.50 | 10.72 |
| Lupin | 4.01 | 3.10 | 6.12 | -4.27 | -8.71 | 41.14 | 16.17 |
| Alkem Laboratories | 4.30 | 3.20 | 15.47 | 11.61 | -2.26 | 20.29 | 16.02 |
| Aurobindo Pharma | 4.77 | 5.10 | 5.60 | -7.30 | -18.14 | 27.67 | 8.06 |
| Abbott India | -1.34 | -2.12 | -13.63 | -4.47 | -0.20 | 14.70 | 13.16 |
| Laurus Labs | 2.36 | 13.77 | 14.00 | 58.86 | 101.49 | 28.34 | 28.79 |
| Glenmark Pharmaceuticals | 1.69 | -6.33 | -10.97 | 31.35 | 8.61 | 63.66 | 29.98 |
| Biocon | 3.92 | 9.50 | -0.58 | 13.22 | 22.27 | 11.53 | -1.52 |
| GlaxoSmithKline Pharmaceuticals | 0.21 | -2.66 | -7.06 | -7.98 | 1.93 | 25.53 | 13.79 |
| Anthem Biosciences | -1.49 | -8.06 | -6.71 | -3.81 | -3.81 | -1.29 | -0.77 |
| Ipca Laboratories | 0.77 | -2.12 | -10.29 | -6.88 | -18.52 | 12.62 | 1.79 |
| Ajanta Pharma | 8.79 | 6.76 | -1.59 | 0.20 | -13.37 | 27.38 | 19.28 |
| Gland Pharma | 0.17 | -1.74 | -3.80 | 34.33 | 18.38 | 1.73 | 0.92 |
Over the last one year, Astal Laboratories has declined 1.83% compared to peers like Sun Pharmaceutical Industries (-6.42%), Divi's Laboratories (15.80%), Cipla (-4.97%). From a 5 year perspective, Astal Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (27.40%) and Divi's Laboratories (16.40%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 98.23 | 97.78 |
| 10 | 99.25 | 98.07 |
| 20 | 97.86 | 96.59 |
| 50 | 89.37 | 92.45 |
| 100 | 88.26 | 89.6 |
| 200 | 85.62 | 86.07 |
In the latest quarter, Astal Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 81.81% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Oct 21, 2025, 10:49 PM IST | Astal Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 14, 2025, 1:21 AM IST | Astal Laboratories - Shareholders Meeting- Notice Of Extra Ordinary General Meeting. |
| Oct 11, 2025, 2:24 AM IST | Astal Laboratories - Shareholders Meeting- EGM 06-11-2025 |
| Oct 10, 2025, 7:27 PM IST | Astal Laboratories - Announcement under Regulation 30 (LODR)-Preferential Issue |
| Oct 10, 2025, 7:21 PM IST | Astal Laboratories - Announcement under Regulation 30 (LODR)-Acquisition |
Astal Laboratories Ltd. is a Public Limited Listed company incorporated on 03/08/1993 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L74120UP1993PLC015605 and registration number is 015605. Currently company belongs to the Industry of Trading. Company's Total Operating Revenue is Rs. 64.23 Cr. and Equity Capital is Rs. 9.85 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Astal Laboratories is ₹96.50 as on Nov 04, 2025.
The Astal Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Astal Laboratories is ₹94.86 Cr as on Nov 04, 2025.
Today’s highest and lowest price of Astal Laboratories are ₹99.00 and ₹95.70.
The 52-week high/low is the highest and lowest price at which Astal Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Astal Laboratories is ₹103.20 and 52-week low of Astal Laboratories is ₹66.72 as on Nov 04, 2025.
The Astal Laboratories has shown returns of -1.13% over the past day, 4.52% for the past month, 9.22% over 3 months, -1.83% over 1 year, 50.07% across 3 years, and 60.05% over 5 years.
P/E ratio of and PB ratio of Astal Laboratories are 10.17 and 4.07 on Nov 04, 2025. While the company gives a dividend yield of 0.00 per annum.